Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.


CSE:QNTM - Post by User

Post by DavidRosenbergon Mar 08, 2023 10:34pm
91 Views
Post# 35327343

How did Celsius holdings grow since Kevin joined them

How did Celsius holdings grow since Kevin joined them
Celsius Holdings started to gain popularity in the mid to late 2010s, particularly as interest in healthy and functional beverages began to grow. The company's flagship product, Celsius, was first introduced in 2005, but it was not until several years later that the brand began to gain traction and expand its reach.
 
Celsius started to gain popularity in 2017-2018 when the company launched a new marketing campaign featuring celebrity endorsements and expanded its distribution channels. In 2018, the company also announced that it had secured distribution deals with major retailers, including Walmart, Target, and CVS, which helped to increase the brand's visibility and availability.
 
Since then, Celsius Holdings has continued to grow in popularity, with the company reporting strong revenue growth in recent years. The company's focus on health and wellness, as well as its commitment to innovation and expanding its product line, has helped it to stand out in a crowded market and appeal to a growing number of consumers looking for healthier beverage options.


Kevin Harrington joined Celsius Holdings as a strategic advisor, investor, and brand ambassador in March 2018, which was around the same time that the company started to gain more widespread popularity. Harrington's involvement with the company helped to bring additional attention to the brand and support its growth and expansion efforts. His experience in sales and marketing, as well as his network of contacts in the industry, were particularly valuable in helping Celsius Holdings to build its brand and reach a wider audience.
<< Previous
Bullboard Posts
Next >>